Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06684678

Individualized Automatic Coaching Message for Glycemic Management and Depressive Symptom

Efficacy of Individualized Automatic Coaching Message Based on the Metrics of Continuous Glucose Monitoring and Depressive Symptom: A Randomized Controlled Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
140 (estimated)
Sponsor
Samsung Medical Center · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This is a single-center, randomized, prospective, confirmatory study of efficacy of individualized automatic coaching message for glycemic management and depressive symptom in patients with type 1 diabetes. The study will enroll patients with type 1 diabetes who are applying continuous glucose monitoring (CGM) and receiving twice-monthly non-face-to-face management by a dedicated education nurse through the Type 1 Diabetes Home Care Project and Educational Consultation program. For 12 weeks, the intervention group will receive weekly personalized coaching messages for glycemic management based on data from continuous glucose monitoring and bi-weekly personalized coaching messages for depression symptoms based on depression questionnaires, instead of non-face-to-face diabetes management. The control group will continue their current treatment and non-face-to-face diabetes management. The aim of this study is to evaluate whether the efficacy of automated, personalized coaching messages for glycemic management and depressive symptoms is non-inferior to the current non-face-to-face management approach in people with type 1 diabetes.

Conditions

Interventions

TypeNameDescription
OTHERindividualized automatic coaching message for glycemic management and depressive symptomFor 12 weeks, the intervention group will receive weekly personalized coaching messages for glycemic management based on data from continuous glucose monitoring and bi-weekly personalized coaching messages for depression symptoms based on depression questionnaires, instead of non-face-to-face diabetes management.

Timeline

Start date
2024-11-13
Primary completion
2025-04-30
Completion
2025-04-30
First posted
2024-11-12
Last updated
2024-11-13

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT06684678. Inclusion in this directory is not an endorsement.